Literature DB >> 12737781

[Smoking cessation and risk of myocardial reinfarction in coronary patients: a nested case-control study].

Manuel Serrano1, Edurne Madoz, Isabel Ezpeleta, Beatriz San Julián, Carlos Amézqueta, José Antonio Pérez Marco, Jokin de Irala.   

Abstract

INTRODUCTION AND
OBJECTIVES: Smoking cessation reduces mortality in coronary patients. The aim of this study was to estimate association measures between the risk of occurrence of fatal or non-fatal reinfarction in patients who either continue to smoke or stop after a first infarction and are treated with secondary prevention measures. PATIENTS AND
METHOD: The study was a case-control (1:1) design nested in a cohort of 985 coronary patients under the age of 76 years who were not treated with invasive procedures and survived more than 6 months after the first acute myocardial infarction. Cases were all patients who suffered reinfarction (n = 137) between 1997 and 2000. A control patient was matched with each case by gender, age, hospital, interviewer, and the secondary prevention timeframe.
RESULTS: Patients who smoke after the first acute myocardial infarction had an Odds ratio (OR) of 2.83 (95% CI, 1.47-5.47) for a new acute myocardial infarction. Adjustment for lifestyle, drug treatment, and risk factors (family history of coronary disease, high blood pressure, hypercholesterolemia, and diabetes mellitus) did not change the OR (2.80 [95% CI, 1.35-5.80]). Patients who quit smoking had an adjusted OR of 0.90 (95% CI, 0.47-1.71) compared with non-smokers before the first acute myocardial infarction. Continued smoking had an adjusted OR of 2.90 (95% CI, 1.35-6.20) compared to quitting after the first acute myocardial infarction.
CONCLUSION: The risk of acute myocardial infarctions is three times higher in patients who continue to smoke after an acute coronary event compared with patients who quit. The risk of reinfarction in patients who stop smoking is similar to the risk of non-smokers before the first infarction.

Entities:  

Mesh:

Year:  2003        PMID: 12737781     DOI: 10.1016/s0300-8932(03)76898-5

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  5 in total

1.  Smoking and a complement gene polymorphism interact in promoting cardiovascular disease morbidity and mortality.

Authors:  G J Arason; J Kramer; B Blaskó; R Kolka; P Thorbjornsdottir; K Einarsdóttir; A Sigfúsdóttir; S T Sigurdarson; G Sigurdsson; Z Rónai; Z Prohászka; M Sasvári-Székely; S Bödvarsson; G Thorgeirsson; G Füst
Journal:  Clin Exp Immunol       Date:  2007-04-11       Impact factor: 4.330

2.  The association among depressive symptoms, smoking status and antidepressant use in cardiac outpatients.

Authors:  Shannon Gravely-Witte; Donna E Stewart; Neville Suskin; Sherry L Grace
Journal:  J Behav Med       Date:  2009-06-06

3.  The impact of passive and active smoking on inflammation, lipid profile and the risk of myocardial infarction.

Authors:  Ritienne Attard; Philip Dingli; Carine J M Doggen; Karen Cassar; Rosienne Farrugia; Stephanie Bezzina Wettinger
Journal:  Open Heart       Date:  2017-08-08

4.  Income-related inequality in smoking cessation among adult patients with cardiovascular disease: a 5-year follow-up of an angiography intervention in Luxembourg.

Authors:  Anastase Tchicaya; Nathalie Lorentz; Stefaan Demarest
Journal:  BMC Cardiovasc Disord       Date:  2017-05-05       Impact factor: 2.298

5.  Tobacco Use in Fibromyalgia Is Associated With Cognitive Dysfunction: A Prospective Questionnaire Study.

Authors:  Lin Ge; Ryan S D'Souza; Terry Oh; Ann Vincent; Arya B Mohabbat; Jason Eldrige; Li Jiang; Mary O Whipple; Samantha J McAllister; Zhen Wang; Wenchun Qu; William D Mauck
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2019-02-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.